Alzheimer’s risk factor FERMT2 promotes the progression of colorectal carcinoma via Wnt/β-catenin signaling pathway and contributes to the negative correlation between Alzheimer and cancer
Fig 1
FERMT2 is highly expressed in the tissues of colorectal cancer (CRC).
(A-E) Comparison of FERMT2 mRNA expression levels between normal and tumor tissues obtained from the Oncomine web tool (Wilcoxon test). P < 0.05 was considered to be statistically significant.